The abnormal upregulation of FOXM1 is involved in the oncogenesis of various human cancers, including breast, lung, bile duct, prostate, brain and pancreatic cancers, in addition to basal cell carcinoma (BCC) and head and neck squamous cell carcinoma (SCC) [9–15]. Here, FOXM1 is linked to familial pancreatic carcinoma.